arrow
S

Susumu Takeuchi

nippon medical school
H指数:20
被引数:1,458

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Retrospective study on the tolerability of anti-PD-L1 antibody plus platinum-etoposide for elderly patients with extensive- stage small-cell lung cancer based on body mass index

基于体质量指数的回顾性研究:PD-L1抗体联合铂类-依托泊苷在广泛期小细胞肺癌老年患者中的耐受性

2024-12-010
PRE
IgA vasculitis induced by carboplatin plus nab-paclitaxel plus pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report
2024-08-140
OAAI
Phosphoproteomic Analysis Identi fied Mutual Phosphorylation of FAK and Src as a Mechanism of Osimertinib Resistance in EGFR-Mutant Lung Cancer

磷酸化蛋白质组学分析证实FAK和Src的相互磷酸化是EGFR突变肺癌中奥希替尼耐药的机制

2024-04-012
OA
A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study)
2024-01-014
PRE
Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLC

铂类双重化疗联合免疫检查点抑制剂治疗晚期非鳞状NSCLC患者TTF-1表达弥漫性阳性的预测作用

2023-11-011
OA
Artificial intelligence analysis of three-dimensional imaging data derives factors associated with postoperative recurrence in patients with radiologically solid-predominant small-sized lung cancers
2021-12-2315
OA